Anyone who’s fought a lifelong battle of the bulge – cutting calories, working out – might wonder why they still can’t lose ...

Roughly three million Canadian adults are now taking GLP-1 drugs, such as Ozempic and Mounjaro, with another two million saying they would like to but are held back by cost and coverage. For health ...

Semaglutide's patent expiry in India could sharply reduce the cost of popular weight-loss and diabetes injections.

Aspen Pharmacare aims to secure sub‑Saharan African approval for Eli Lilly's blockbuster weight‑loss drug Mounjaro as early ...